Sukumar Nagendran

CIK 1665124 · President and Head of R&D · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.88M

Companies

3

Total Filings

44

Lifetime Open-Market Net

-$6.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SLDB Director 34,258 $7.14 $244.6K $0 12 2026-06-11
TSHA President and Head of R&D 1,336,410 $5.71 $7.63M -$4.80M 16 2026-04-13
AveXis, Inc. (AVXS) Delisted Sr. VP & Chief Medical Officer 0 -$2.03M 16 2018-05-15

Recent Filings · Page 3 of 5

44 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-21 SLDB Grant (A) $0 EDGAR
2020-09-30 TSHA Conv (C) +19,226 $0 EDGAR
2020-09-25 TSHA Grant (A) $0 EDGAR
2020-06-18 SLDB Grant (A) $0 EDGAR
2019-07-29 SLDB Grant (A) +32,258 $150.0K EDGAR
2019-06-14 SLDB Grant (A) $0 EDGAR
2018-12-17 SLDB Grant (A) $0 EDGAR
2018-09-13 SLDB Grant (A) $0 EDGAR
2018-05-15 AveXis, Inc. (AVXS) Delisted Mixed −3,800 $0 EDGAR
2018-03-27 AveXis, Inc. (AVXS) Delisted Grant (A) +3,800 $0 EDGAR
Showing 2130 of 44
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.